Congenital rubella after successful vaccination

Area of Science:

• Virology
• Immunology
• Maternal-Fetal Medicine

Background:

• Rubella infection during pregnancy poses significant risks of congenital abnormalities.
• Vaccination is the primary method for preventing rubella.
• Subclinical infections can evade detection but still pose risks.

Observation:

• A pregnant patient with a history of rubella virus vaccine (Cendevax) developed a subclinical rubella infection in the first trimester.
• The patient demonstrated seroconversion post-vaccination, indicating an immune response prior to pregnancy.

Findings:

• The subclinical rubella infection resulted in the delivery of a neonate with congenital rubella syndrome.
• Despite documented seroconversion from the rubella vaccine, the infection was transmitted to the fetus.

Implications:

• This case underscores the possibility of vaccine failure or waning immunity against rubella.
• It highlights the need for continued vigilance and potential re-evaluation of rubella immunity status in pregnant individuals.
• Further research into the long-term efficacy of rubella vaccines and management of subclinical infections in pregnancy is warranted.